Celiac Disease Market

Dec 06, 2024

At present, there are no FDA-approved celiac disease therapies in the therapeutic segment. The only available treatment is a strict, lifelong gluten-free diet, which can be costly and challenging to follow. Many patients experience incomplete intestinal healing and persistent symptoms, often due to difficulties in ...

Dec 02, 2024

Celiac disease is considered a serious autoimmune disease, which is estimated to affect 1 in 100 people worldwide. Moreover, 2.5 million Americans are undiagnosed and are at risk for long-term health complications.  As per secondary, commonly known clinical types of celiac disease include Classical, Non-cla...

Aug 14, 2020

The contribution of key pharma companies, such as 9 Meters Biopharma, ImmunogenX, Provention Bio, Cour Pharmaceuticals/Takeda, Precigen ActoBio, Falk Pharma, and Zedira is significant in driving Celiac disease market size. Who would have thought that consumption of gluten can trigger an autoimmune disorder? Alth...

Nov 28, 2017

Celiac disease is a serious chronic, autoimmune disorder that can occur in genetically predisposed people. The ingestion of gluten (a protein found in wheat, rye and barley) by a person suffering from celiac disease leads to damage in the small intestine. Celiac disease can be difficult to diagnose because it affect...